APA (7th ed.) Citation

KG, Y., AP, M., R, H., TT, J., PM, C., RR, H., . . . JM, D. (2026). Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study. Diabetes care, 49(6), 1115. https://doi.org/10.2337/dc25-2973

Chicago Style (17th ed.) Citation

KG, Young, et al. "Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study." Diabetes Care 49, no. 6 (2026): 1115. https://doi.org/10.2337/dc25-2973.

MLA (9th ed.) Citation

KG, Young, et al. "Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study." Diabetes Care, vol. 49, no. 6, 2026, p. 1115, https://doi.org/10.2337/dc25-2973.